A Study of BGM0504 Injection in Participants with Obesity or Overweight

Clinical trial NCT06704581 · RECRUITING

Trial details

NCT number: NCT06704581
Sponsor: BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2024-10-28
Primary completion: 2025-11-27
Enrollment: 620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.